R

Rapid Dose Therapeutics Corp
CNSX:DOSE

Watchlist Manager
Rapid Dose Therapeutics Corp
CNSX:DOSE
Watchlist
Price: 0.145 CAD 3.57% Market Closed
Market Cap: 19.4m CAD

Rapid Dose Therapeutics Corp
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Rapid Dose Therapeutics Corp
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
R
Rapid Dose Therapeutics Corp
CNSX:DOSE
Net Income (Common)
-CA$5.4m
CAGR 3-Years
14%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Net Income (Common)
CA$2.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Imaging Dynamics Co Ltd
XTSX:IDL
Net Income (Common)
-CA$1.1m
CAGR 3-Years
1%
CAGR 5-Years
18%
CAGR 10-Years
5%
Aurora Spine Corp
XTSX:ASG
Net Income (Common)
-$1.3m
CAGR 3-Years
5%
CAGR 5-Years
-12%
CAGR 10-Years
12%
N
NuGen Medical Devices Inc
XTSX:NGMD
Net Income (Common)
-CA$5.2m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
Ondine Biomedical Inc
LSE:OBI
Net Income (Common)
-CA$19.1m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Rapid Dose Therapeutics Corp
Glance View

Market Cap
19.1m CAD
Industry
N/A

Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The firm provides drug-delivery technologies. The firm also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries. The company owns an oral fast-dissolving drug delivery system, QuickStrip, which is capable of releasing into the blood stream a list of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver. Its QuickStrip Energy product delivers energizing caffeine. Its QuickStrip B12 product delivers vitamin B12 to user's system, assisting with metabolism and physical energy. Melatonin is its QuickStrip Sleep product that delivers melatonin to the user's system. The RDMx mixture is its formulation, which is processed using RDT production equipment.

DOSE Intrinsic Value
0.066 CAD
Overvaluation 55%
Intrinsic Value
Price
R

See Also

What is Rapid Dose Therapeutics Corp's Net Income (Common)?
Net Income (Common)
-5.4m CAD

Based on the financial report for Feb 28, 2025, Rapid Dose Therapeutics Corp's Net Income (Common) amounts to -5.4m CAD.

What is Rapid Dose Therapeutics Corp's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
7%

Over the last year, the Net Income (Common) growth was -25%. The average annual Net Income (Common) growth rates for Rapid Dose Therapeutics Corp have been 14% over the past three years , 7% over the past five years .

Back to Top